LAM KID - 2012;2(02)

Content

Journal Previous issue Next number Archives

LAM KID

JULY 03, 2012

[Bone status in praediabetic state - Relationship of bone density and energy homeostasis before the manifestation of type 2 diabetes mellitus]

BUDAY BARBARA, VITAI Márta, PACH Péter, LITERÁTI Nagy Botond, PÉTERFAI Éva, BEZZEGH Katalin, PAUER József, KORÁNYI LÁSZLÓ

[INTRODUCTION - All forms of diabetes are associated with increased fracture risk. In type 2 diabetes, bone mineral density is increased. In order to determine whether increased bone density is a consequence of diabetes-related metabolic changes or rather a primary alteration independent of these changes, we examined women and men with the following characteristics: normal glucose tolerance; genetically determined risk of T2DM but healthy on the basis of detailed metabolic tests; or incipient... tovább »

PDF| Summary Cite COPYRIGHT FEES

HUN

2012;2(02)

LAM KID

JULY 03, 2012

[Secondary osteoporosis in gastrointestinal diseases]

FUSZEK Péter

[Gastrointestinal disease is often overlooked or simply forgotten as a cause of osteoporosis. In a number of gastrointestinal diseases, sometimes because of the medicines used for their treatment, malabsorption syndrome may occur. Malabsorption might lead to insufficient absorption of calcium, phosphate, magnesium, vitamin D, vitamin K and proteins, which can cause osteopenia, osteoporosis and osteomalacia. In this paper, we aim to review the gastroenterological diseases that can lead to... tovább »

PDF| Summary Cite COPYRIGHT FEES

HUN

2012;2(02)

LAM KID

JULY 03, 2012

[Practical questions regarding the use of teriparatide]

TAKÁCS István

[Teriparatide has become one of the most important drug in the treatment of osteoporosis in Hungary. Although this is not a new drug, a number of questions arise regarding its use in everyday practice. When should we use it as first-line treatment? When should we change the used therapy to teriparatide? What kind of effect can we expect after the start of teriparatide therapy? What are the potential side effects? Financing rules limit, but do not fully control our therapeutic decisions, as... tovább »

PDF| Summary Cite COPYRIGHT FEES

HUN

2012;2(02)

LAM KID

JULY 03, 2012